Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 37.52% vs 28.49% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 213.44% vs 149.83% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 94.74% vs 67.06% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 288.37% vs 310.76% in Mar 2024
Compare Profit and Loss Results of Aptus Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
24.00
368.00
-344.00
-93.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
34.00
-34.00
-100.00%
Net Sales
24.00
333.00
-309.00
-92.79%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
4.00
-7.00
-175.00%
Raw Materials Consumed
12.00
164.00
-152.00
-92.68%
Power & Fuel Cost
0.00
27.00
-27.00
-100.00%
Employee Cost
3.00
45.00
-42.00
-93.33%
Operating Expenses
1.00
28.00
-27.00
-96.43%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
4.00
-1.00
-25.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
7.00
-7.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
289.00
-270.00
-93.43%
Operating Profit (PBDIT) excl Other Income
4.00
44.00
-40.00
-90.91%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
4.00
48.00
-44.00
-91.67%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
4.00
40.00
-36.00
-90.00%
Depreciation
0.00
10.00
-10.00
-100.00%
Profit Before Taxation & Exceptional Items
4.00
30.00
-26.00
-86.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
30.00
-26.00
-86.67%
Provision for Tax
1.00
8.00
-7.00
-87.50%
Profit After Tax
3.00
21.00
-18.00
-85.71%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
101.00
-100.00
-99.01%
Profit Available for appropriations
4.00
122.00
-118.00
-96.72%
Appropriations
4.00
122.00
-118.00
-96.72%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
6.37
70.69
-64.32
-90.99%
Profit And Loss - Net Sales
Net Sales 24.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.52% vs 28.49% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 213.44% vs 149.83% in Mar 2024
Profit And Loss - Interest
Interest 0.47 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 94.74% vs 67.06% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 3.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 288.37% vs 310.76% in Mar 2024






